Peptide record

TPDB11939

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
41 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11939
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP Peptipedia AFP-GFuse Antifungipept CAFPdb
standard
No
A 41-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
DTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C177H289N57O55S6
NEMY
CS
4287.95
8.60
7
2
11
+4
1.65
-0.129
52.44
Mammalian: 1.1 hour Yeast: 3 min E.coli: >10 hour
5875
1.37
15
Residue Composition
number
4
A
3
R
0
N
2
D
6
C
0
E
1
Q
4
G
1
H
1
I
2
L
3
K
0
M
1
F
2
P
6
S
2
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 4 R: 3 N: 0 D: 2 C: 6 E: 0 Q: 1 G: 4 H: 1 I: 1 L: 2 K: 3 M: 0 F: 1 P: 2 S: 6 T: 2 W: 1 Y: 0 V: 2
Chemical Descriptors
41 reviewed residue count
C177H289N57O55S6 sequence-only estimate (linear, free termini)
4287.95 sequence-only estimate (linear, free termini)
8.60 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
1.65 sequence-only estimate (linear, free termini)
-0.129 sequence-only estimate (linear, free termini)
Evidence Records 32 records
Evidence 1 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

C. jejuni

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
The synthetic peptide is tested against Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (M
Evidence 2 Activity

Activity

MIC
Antibacterial
>128 µg/mL

Target

S.enterica serovar Typhimurium

Source & Reference

dbAMP

Other

The synthetic peptide is tested against Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml)
Evidence 3 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP

Other

Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug
Evidence 4 Activity

Activity

MIC
Antibacterial
>128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP

Other

(MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/m
Evidence 5 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Clostridium perfringens

Source & Reference

dbAMP

Other

Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fung
Evidence 6 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

Streptococcus pyogenes

Source & Reference

dbAMP

Other

E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml)
Evidence 7 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP

Other

S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml) and S. cerevisiae (MIC 8 ug/ml). The recombinant form is similarly or less active. Since
Evidence 8 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

S. cerevisiae

Source & Reference

dbAMP

Other

aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml) and S. cerevisiae (MIC 8 ug/ml). The recombinant form is similarly or less active. Since it has a different sequence, it
Evidence 9 Activity

Activity

MIC
Antifungal
64 µg/mL

Target

C. jejuni

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
The synthetic peptide is tested against Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (M
Evidence 10 Activity

Activity

MIC
Antifungal
>128 µg/mL

Target

S.enterica serovar Typhimurium

Source & Reference

dbAMP CAFPdb Antifungipept

Other

The synthetic peptide is tested against Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml)
Evidence 11 Activity

Activity

MIC
Antifungal
64 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug
Evidence 12 Activity

Activity

MIC
Antifungal
>128 µg/mL

Target

P.aeruginosa

Source & Reference

dbAMP CAFPdb Antifungipept

Other

(MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/m
Evidence 13 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Clostridium perfringens

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fung
Evidence 14 Activity

Activity

MIC
Antifungal
64 µg/mL

Target

Streptococcus pyogenes

Source & Reference

dbAMP CAFPdb Antifungipept

Other

E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml)
Evidence 15 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml) and S. cerevisiae (MIC 8 ug/ml). The recombinant form is similarly or less active. Since
Evidence 16 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

S. cerevisiae

Source & Reference

dbAMP CAFPdb Antifungipept

Other

aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml) and S. cerevisiae (MIC 8 ug/ml). The recombinant form is similarly or less active. Since it has a different sequence, it
Evidence 17 Activity

Activity

MIC
Antiparasitic
64 µg/mL

Target

C. jejuni

Source & Reference

NA

Other

The synthetic peptide is tested against Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (M
Evidence 18 Activity

Activity

MIC
Antiparasitic
>128 µg/mL

Target

S.enterica serovar Typhimurium

Source & Reference

NA

Other

The synthetic peptide is tested against Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml)
Evidence 19 Activity

Activity

MIC
Antiparasitic
64 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug
Evidence 20 Activity

Activity

MIC
Antiparasitic
>128 µg/mL

Target

P.aeruginosa

Source & Reference

NA

Other

(MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/m
Evidence 21 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

Clostridium perfringens

Source & Reference

NA

Other

Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fung
Evidence 22 Activity

Activity

MIC
Antiparasitic
64 µg/mL

Target

Streptococcus pyogenes

Source & Reference

NA

Other

E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml)
Evidence 23 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

Candida albicans

Source & Reference

NA

Other

S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml) and S. cerevisiae (MIC 8 ug/ml). The recombinant form is similarly or less active. Since
Evidence 24 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

S. cerevisiae

Source & Reference

NA

Other

aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml) and S. cerevisiae (MIC 8 ug/ml). The recombinant form is similarly or less active. Since it has a different sequence, it
Evidence 25 Activity

Activity

MIC
Antiviral
64 µg/mL

Target

C. jejuni

Source & Reference

NA

Other

The synthetic peptide is tested against Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (M
Evidence 26 Activity

Activity

MIC
Antiviral
>128 µg/mL

Target

S.enterica serovar Typhimurium

Source & Reference

NA

Other

The synthetic peptide is tested against Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml)
Evidence 27 Activity

Activity

MIC
Antiviral
64 µg/mL

Target

Escherichia coli

Source & Reference

NA

Other

Gram- bacteria C. jejuni (MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug
Evidence 28 Activity

Activity

MIC
Antiviral
>128 µg/mL

Target

P.aeruginosa

Source & Reference

NA

Other

(MIC 64 ug/ml), S.enterica serovar Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/m
Evidence 29 Activity

Activity

MIC
Antiviral
8 µg/mL

Target

Clostridium perfringens

Source & Reference

NA

Other

Typhimurium (MIC >128 ug/ml), E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fung
Evidence 30 Activity

Activity

MIC
Antiviral
64 µg/mL

Target

Streptococcus pyogenes

Source & Reference

NA

Other

E. coli (MIC 64 ug/ml), P.aeruginosa (MIC>128 ug/ml), Gram+ C. perfringens (MIC 8 ug/ml), S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml)
Evidence 31 Activity

Activity

MIC
Antiviral
8 µg/mL

Target

Candida albicans

Source & Reference

NA

Other

S. pyogenes (MIC 64 ug/ml), S.aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml) and S. cerevisiae (MIC 8 ug/ml). The recombinant form is similarly or less active. Since
Evidence 32 Activity

Activity

MIC
Antiviral
8 µg/mL

Target

S. cerevisiae

Source & Reference

NA

Other

aureus (MIC > 128 ug/ml), B.cereus (MIC > 128 ug/ml), fungi C. albicans (MIC 8 ug/ml) and S. cerevisiae (MIC 8 ug/ml). The recombinant form is similarly or less active. Since it has a different sequence, it